

Episode 097: Treatment of Relapsed/Refractory CLL
Mar 27, 2024
Dive into the complexities of managing relapsed chronic lymphocytic leukemia (CLL) with insights on treatment strategies and patient care. Discover the challenges of diagnosing Richter's transformation and the impact of key therapies like obinutuzumab and venetoclax. Learn about the significance of genetic markers in prognosis and the evolving landscape of second-line treatments, including the implications of recent market withdrawals. Nostalgic discussions about childhood animated films add a light-hearted touch to this serious topic.
Chapters
Transcript
Episode notes